Data

B-lactoglobulin-Modified Mesoporous Silica Nanoparticles, A Promising Carrier for the Targeted Delivery of Fenbendazole into Prostate Cancer Cells

Queensland University of Technology
Koohi Moftakhari Esfahani, Maedeh ; Alavi, Seyedebrahim ; J. Cabot, Peter ; Islam, Nazrul ; L. Izake, Emad
Viewed: [[ro.stat.viewed]] Cited: [[ro.stat.cited]] Accessed: [[ro.stat.accessed]]
ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Adc&rfr_id=info%3Asid%2FANDS&rft_id=info:doi10.25912/RDF_1660607767379&rft.title=B-lactoglobulin-Modified Mesoporous Silica Nanoparticles, A Promising Carrier for the Targeted Delivery of Fenbendazole into Prostate Cancer Cells&rft.identifier=10.25912/RDF_1660607767379&rft.publisher=Queensland University of Technology&rft.description=Fenbendazole, which is an anthelmintic, was encapsulated into succinylated beta-lactoglobulin-modified, amine-functionalised mesoporous silica nanoparticles to protect the drug throughout gastrointestinal tract and improve its anticancer effects against prostate cancer. The data resulting from this study include the Higuchi kinetic model of the drug release and the toxicity effects of the prepared formulations against HEK-293 cells. &rft.creator=Koohi Moftakhari Esfahani, Maedeh &rft.creator=Alavi, Seyedebrahim &rft.creator=J. Cabot, Peter &rft.creator=Islam, Nazrul &rft.creator=L. Izake, Emad &rft.date=2022&rft.edition=1&rft.relation=https://eprints.qut.edu.au/229955/&rft.coverage=153.317870,-26.996845 152.668523,-26.996845 152.668523,-27.767441 153.317870,-27.767441 153.317870,-26.996845&rft_rights=© Maedeh Koohi Moftakhari Esfahani, 2022.&rft_rights=Creative Commons Attribution 3.0 http://creativecommons.org/licenses/by/4.0/&rft_subject=Nanotechnology&rft_subject=ENGINEERING&rft_subject=Biotechnology&rft_subject=Biomaterials&rft_subject=Biomedical engineering&rft.type=dataset&rft.language=English Access the data

Licence & Rights:

Open Licence view details
CC-BY

Creative Commons Attribution 3.0
http://creativecommons.org/licenses/by/4.0/

© Maedeh Koohi Moftakhari Esfahani, 2022.

Access:

Other

Contact Information

Postal Address:
Mrs Maedeh Koohi Moftakhari Esfahani

maedeh.koohi@hdr.qut.edu.au

Full description

Fenbendazole, which is an anthelmintic, was encapsulated into succinylated beta-lactoglobulin-modified, amine-functionalised mesoporous silica nanoparticles to protect the drug throughout gastrointestinal tract and improve its anticancer effects against prostate cancer.

The data resulting from this study include the Higuchi kinetic model of the drug release and the toxicity effects of the prepared formulations against HEK-293 cells.

Data time period: 07 2020 to 30 03 2022

Click to explore relationships graph

153.317870,-26.996845 152.668523,-26.996845 152.668523,-27.767441 153.317870,-27.767441 153.317870,-26.996845

152.9931965,-27.382143

Subjects

User Contributed Tags    

Login to tag this record with meaningful keywords to make it easier to discover

Identifiers